Barclays Cuts Adient (NYSE:ADNT) Price Target to $25.00

Adient (NYSE:ADNT) had its price target reduced by Barclays from $29.00 to $25.00 in a research note issued to investors on Monday morning,Benzinga reports. Barclays currently has an equal weight rating on the stock.

ADNT has been the subject of several other research reports. JPMorgan Chase & Co. lowered their price target on shares of Adient from $28.00 to $26.00 and set a “neutral” rating for the company in a research report on Thursday, April 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $28.00 price objective on shares of Adient in a research note on Thursday, August 6th. Citigroup raised shares of Adient from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $30.00 to $33.00 in a report on Wednesday, April 15th. Wells Fargo & Company upped their target price on shares of Adient from $28.00 to $32.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th. Finally, UBS Group reduced their price target on Adient from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Six research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Adient has a consensus rating of “Hold” and a consensus target price of $26.70.

Adient Trading Down 2.4%

Shares of ADNT opened at $18.68 on Monday. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. Adient has a 12-month low of $17.68 and a 12-month high of $27.32. The firm has a market capitalization of $1.44 billion, a PE ratio of 31.13, a price-to-earnings-growth ratio of 0.38 and a beta of 1.52. The stock’s fifty day simple moving average is $20.34 and its 200-day simple moving average is $21.49.

Adient (NYSE:ADNT) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.08). The firm had revenue of $3.93 billion during the quarter, compared to analyst estimates of $3.71 billion. Adient had a return on equity of 7.32% and a net margin of 0.32%.Adient’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 earnings per share. As a group, research analysts predict that Adient will post 2.04 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Heather M. Tiltmann sold 22,000 shares of Adient stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $22.71, for a total transaction of $499,620.00. Following the transaction, the executive vice president directly owned 110,886 shares of the company’s stock, valued at $2,518,221.06. This trade represents a 16.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.94% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Parallel Advisors LLC grew its position in Adient by 19.4% in the first quarter. Parallel Advisors LLC now owns 3,186 shares of the company’s stock valued at $64,000 after purchasing an additional 517 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Adient by 10.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 7,538 shares of the company’s stock worth $152,000 after buying an additional 705 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its position in Adient by 9.3% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 10,162 shares of the company’s stock worth $193,000 after buying an additional 866 shares in the last quarter. Corient Private Wealth LLC boosted its stake in shares of Adient by 5.2% during the 4th quarter. Corient Private Wealth LLC now owns 18,117 shares of the company’s stock worth $347,000 after buying an additional 899 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in shares of Adient by 1.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 92,947 shares of the company’s stock worth $1,782,000 after buying an additional 1,065 shares during the last quarter. 92.44% of the stock is currently owned by institutional investors.

Adient Company Profile

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.